Latest news
November 6, 2003
Debiopharm presents results of a first monthly injectable sustained-release fomulation of ZT-1 for Alzheimer´s Disease
October 23, 2003
Debiopharm and Tulane Cancer Center select Hemenway as the 2003 Mauvernay Research Excellence Scholar
October 20, 2003
Debiopharm SA starts a Phase II trial for a once daily oral formulation of ZT-1 to treat Alzheimer´s
July 29, 2003
Debiopharm S.A. and Dyax Corp. granted European Orphan Drug Status for EPI-hNE4 (DX-890) for Cystic Fibrosis Indication
July 24, 2003
H3 Pharma Inc. announces important step in bringing SANVAR® (vapreotide) to U.S. market
November 19, 2002
Debiopharm S.A. announces a patent application on a hydrosoluble prodrug of cyclosporin A